The Foundation’s Board of Trustees is comprised of highly successful thought leaders with extensive experience in science, biomedical research, healthcare, medical device and pharmaceutical industries, finance, education, and government and regulatory agencies. It is the enthusiasm and energy of this group that propels the Foundation forward.
Philip Keevil, MA (Oxon), MBA, FRSA
Philip C. Keevil, MA (Oxon), MBA, FRSA, is the Chairman of the UK Focused Ultrasound Foundation and an Advisor to the Charlottesville, Virginia based Focused Ultrasound Foundation. Mr. Keevil has over 40 years of private equity and investment banking experience as well as extensive experience with not-for-profit entities. His particular expertise is in cross border M&A. In 2005 he became a Partner in Compass Partners Advisors LLP, a privately held, corporate finance and M&A advisory firm based in New York and London. From 2006 to 2014, he also served as Chairman of the Risk Advisory Group, a leading international risk, security and investigation consulting firm. From 1995 to 2005, he served as Citi’s Salomon Brothers’ Head of M&A in New York, and starting in 1997, he served as Head of EMEA M&A and Chairman of its European Equity and Fixed Income Commitment Committees. During that time, he advised such European corporations as ABB, GlaxoSmithKline, Holcim, Merck KGaA, Roche, Shell, Syngenta, Tesco and Volkswagen AG. Prior to Salomon/Citi, Mr. Keevil was responsible for S.G. Warburg’s corporate finance and equity capital markets businesses in North America. Before joining S.G. Warburg (now UBS) in 1987 as head of US M&A, he was a General Partner at Lazard Frères & Co. in New York and served as a Co-Head of its International Department. Mr. Keevil began his investment banking career in 1975 at Morgan Stanley in New York. Before business school, he worked for Unilever in England for five years as a member of its Management Development Scheme.
Mr. Keevil is a member of the Advisory Council of the London Symphony Orchestra and a Trustee of its American Foundation. He is a Freeman of the City of London and a Liveryman of the International Bankers’ and Poulters’ Companies, where he was Master in 2000. He served as a Director of BritishAmerican Business Inc. and Vice Chairman of its predecessor the British American Chamber of Commerce. Mr. Keevil was a founding member of the Business Advisory Forum of Oxford’s Saïd Business School and was a member of the European Advisory Board of Sponsors for Educational Opportunities (SEO). He has been a Governor of the City of London School for Girls and a trustee of St. Bernard’s School in New York and St. Andrew’s School in Delaware. Mr. Keevil is a Fellow of the Royal Society of Arts. Mr. Keevil holds BA and MA degrees with honors in Mathematics, Philosophy, Politics, and Economics from Oxford University, and an MBA degree from Harvard University with high distinction as a Baker Scholar.
The Lord Aberdare, MA (Oxon), DL
Alastair Aberdare was elected as an independent (Crossbench) hereditary member of the House of Lords in 2009. His interests include education, skills and employment, pancreatic cancer, the arts (especially classical music), Welsh affairs and corporate responsibility issues.
Alastair worked for IBM for 21 years in the UK, USA and Belgium, before leaving to set up one of the UK’s first dedicated Public Affairs consultancies, later extended to advise on corporate reputation management more broadly. Subsequently he was a founder director of a small business helping to prepare unemployed and disadvantaged young Londoners for work.
He has served as a Trustee of charities including the National Botanic Garden of Wales, St John Cymru–Wales, the National Library of Wales and the Parliament Choir (in which he sings). Current Trusteeships include the Berlioz Society (of which he is Chairman), the Stephen Dodgson Charitable Trust and the UK Focused Ultrasound Foundation. Alastair is an Honorary Fellow of Cardiff University and a Deputy Lieutenant of Dyfed. He is married to Libby, with two grown-up children and two grandchildren.
John Bowis OBE, MA (Oxon)
John Bowis is Patron of Health First Europe; Patron of Apex Trust; Patron Fund for Epilepsy. Chairs Health Advisory Board, GSK; Adviser to FIPRA. Board Member: Global Initiative on Psychiatry, Gamian Europe, European Men’s Health Forum, Sane, and Maastricht University Health Faculty; Vice President, European Brain Council, Diabetes UK, Epilepsy Research UK; Ambassador, National Aids Trust and Alzheimer’s Society.
John Bowis was a Member of the European Parliament for London (1999-
2009) and EPP Group Coordinator/Spokesman on Environment, Health and
Food Safety, Member of the Development Committee and Vice President
of Africa, Caribbean and Pacific Joint Parliamentary Assembly.
He was responsible (rapporteur) for legislation inter alia on Food Safety, Health & Enlargement, Professional Qualifications, Health & Poverty in Development Policy, the establishment of the ECDC (European Centre for Disease Prevention & Control, Patient Mobility, Mental Health, Neglected Diseases, and Cross Border Healthcare.
He is a former International Policy Adviser to the World Health Organisation and former Member of UK Parliament for Battersea. He served as PPS at Environment and then the Welsh Office, Health Minister 1993-6 and Transport Minister 1996-7.
He currently chairs a range of round tables on Access to Medicines, Value of Health, HIV, Obesity, Rare Diseases,Bone Health, Biosimilars and Personalised Medicine.
He is a past Board Member of the Royal National Theatre, the London Actors’ Theatre Company and BAC. He was elected an Hon. Fellow of the Royal College of Psychiatrists 2003 and Hon. Fellow of the Royal College of Physicians 2009, He was the first recipient of the European Public Health Alliance Award for Service to Public Health 2009.
Sir Ivor Roberts, KCMG, MA (Oxon), FCIL
Born in 1946 in Liverpool. Open Scholarship in Modern Languages at Keble College, Oxford. HM Diplomatic Service 1968-2006. Served in Lebanon, Paris, Luxembourg, Canberra, Vanuatu (formerly New Hebrides), was Minister in the British Embassy in Madrid and Ambassador in Belgrade, Dublin and Rome. He was head of counterterrorism in the Foreign Office in the 1980s.
From January 1998 to February 1999 he was on a sabbatical as a Senior Associate Member of St. Antony’s College, Oxford, writing and lecturing on his experiences in Yugoslavia.
Sir Ivor speaks fluent Italian, French and Spanish and very rusty Serbo-Croatian. His hobbies include Italian opera, theatre, photography and sport (skiing, golf). He was for many years a rugby referee and is now President of Oxford University Rugby Football Club.
Sir Ivor is an Honorary Fellow of Keble College Oxford and Trinity College Oxford. He is a Fellow of the Chartered Institute of Linguists (FCIL), a Patron of the Venice in Peril Fund and was Chairman of the Council of the British School of Archaeology and Fine Art in Rome from 2007-2012. He chairs the Trustees of the Oxford Philharmonic Orchestra and the Keats-Shelley Memorial Association.
He was made a Knight Commander of the Order of St. Michael and St. George (KCMG) in 2000.
He retired from the Diplomatic Service in September 2006 on his election as the President of Trinity College, a post he held until 2017. He is a Visiting Professor at St Mary’s College, London.
In 2009, he published, as editor and major contributor, the first new edition for 30 years of the classic reference book on diplomacy ‘Satow’s Diplomatic Practice’ (Oxford University Press). A further revised, centenary edition was published at the beginning of 2017. His book on his experiences in Yugoslavia during the Bosnian war and the Kosovo crisis, Conversations with Milošević, was published in 2016.
Neal Kassell, MD
Dr. Neal Kassell is the representative of the US based Focused Ultrasound Foundation, the sole member of the UK Focused Ultrasound Foundation. He is the founder and chairman of the US based Foundation and former Co-Chair of Neurosurgery at the University of Virginia. He has published more than 500 scientific papers and book chapters, and his research has been supported by over $30 million in NIH and industry grants and contracts. A member of numerous medical societies in the United States and abroad, he has served on many standing and ad hoc committees of the National Institutes of Health and in an editorial capacity for a variety of academic journals. In April 2016, he was named to the Blue Ribbon Panel of Vice President Joe Biden’s Cancer Moonshot Initiative. Dr. Kassell is a founder of numerous private ventures including Interax, Inc.; the Virginia Neurological Institute; Multimedia Medical Systems, Inc.; the Neuroclinical Trials Center; the NeuroVenture Fund; and MedSpecialists.net. He has served on a number of corporate and not-for-profit boards, including Eclypsis Corporation; INC Research; the Prostate Cancer Foundation; Insightec, Ltd.; the Expedition Trust Company; Tuesday Evening Concert Series and Virginia National Bank, and is currently a director of the Focused Ultrasound Foundation. He is a shareholder in Insightec, Ltd., where he also served on the board until 2012. Dr. Kassell received his undergraduate and medical education at the University of Pennsylvania.
Lacie Riseborough has over 16 years experience working in the philanthropy sector and has led successful, multi-disciplinary fundraising teams; managing seven figure partnerships across various sectors inclusive of education, sport, health and research. Her background includes heading up the Partnerships & Philanthropy team at Netball Western Australia, where she developed strong relations with Federal and State government, the Gold Industry, women in elite sport and at-risk Aboriginal girls across the country. Ms. Riseborough has also worked across various medical research projects; disseminating complex data into understandable and digestible evidence for support to funders and prospective donors.
A passionate advocate for growing not for profit opportunity, Ms. Riseborough is highly skilled in relationship management, implementing sustainable funding models and collaborating with experts across industry. She completed her undergraduate Honours degree in Business Management at Royal Holloway, University of London.
Chrit Moonen, PhD
Professor Chrit Moonen serves the UK Focused Ultrasound Foundation as UK Scientific Programmes Director. He has spent nearly 30 years in the field of focused ultrasound, most recently as professor in the Division of Imaging at the University Medical Center (UMC) in Utrecht, the Netherlands. There, he participated in clinical trials exploring focused ultrasound for bone metastases, breast cancer, and histotripsy in combination with immunotherapy. Under his leadership, UMC Utrecht became the tenth Focused Ultrasound Center of Excellence. Prof. Moonen also serves as Scientific Programs Director at the US-based Focused Ultrasound Foundation.
Emily White, MD
Emily White, MD, serves as the secretary of the of the UK Focused Ultrasound Foundation. She joined the Charlottesville, Virginia based Focused Ultrasound Foundation in 2016 as Director of Operations. Prior to joining the Foundation, Dr. White was a private consultant working in operations and business development support in the healthcare and medical start-up space. Her clients have included everything from a 4,000+ employee, publicly traded, health care company to a brand new start-up with two employees. Her background includes training in general surgery, leadership positions in several highly technical start-up companies with federal clients, non-profit executive management and over 25 years of grant writing experience. She completed her undergraduate degree in Biology & Anthropology at Smith College, holds certification for Community Conflict Resolution from Loyola Law School, and is a University of Virginia School of Medicine graduate. In 2018, Emily expanded her role to include Managing Director of FUS Partners, the Foundation’s efforts to help the FUS industry’s commercialization efforts and expand their access to the MedTech capital markets.
The UK Focused Ultrasound Foundation takes responsibility to our donors seriously, and we uphold the highest standards of fiscal responsibility and integrity. You can be sure your investment will be spent wisely and will make the most impact possible in our efforts to improve lives by accelerating the development and adoption of focused ultrasound.